4.2 Review

New insights into the role of anabolic interventions in dialysis patients with protein energy wasting

Journal

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
Volume 18, Issue 6, Pages 469-475

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MNH.0b013e328331489d

Keywords

anabolic agents; dialysis; exercise; nutritional supplementation; protein-energy wasting

Funding

  1. National Institutes of Health [R01-DK45604, R01-1-11-070938, K24-DK62849, UL1 RR024975]

Ask authors/readers for more resources

Purpose of review Patients on maintenance dialysis commonly develop protein-energy wasting (PEW), which is associated with poor survival. There have been several advances in anabolic interventions aimed at improving PEW in these patients in recent years. Recent findings Oral or parenteral nutritional supplementation, especially if administered during dialysis, improves net protein anabolism in chronic hemodialysis patients. These beneficial effects have been extended to long-term benefits in recent clinical trials. Resistance exercise, alone or combined with intradialytic oral nutrition supplementation, also improves net protein balance in the acute setting although recent studies indicated a limited beneficial effect of long-term exercise alone on muscle protein accretion in chronic hemodialysis patients. Anabolic agents such as growth hormone and androgens have been shown to exert significant benefits on visceral protein stores, muscle mass and strength. Ghrelin, a hormone with combined orexigenic and anti-inflammatory effects, is a potential new nutritional intervention in maintenance dialysis patients. Summary Existing anabolic therapeutic strategies have proven to be effective in improving PEW in maintenance dialysis patients. Combined anabolic interventions and several new and established anabolic hormones represent further promising nutritional interventions. Large-scale randomized controlled trials examining the effects of anabolic interventions on mortality and morbidity are still lacking.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Urology & Nephrology

Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney Injury

Sandeep Brar, Kathleen D. Liu, Alan S. Go, Raymond K. Hsu, Vernon M. Chinchilli, Steven G. Coca, Amit X. Garg, Jonathan Himmelfarb, T. Alp Ikizler, James Kaufman, Paul L. Kimmel, Chirag R. Parikh, Edward D. Siew, Lorraine B. Ware, Hui Zeng, Chi-yuan Hsu

Summary: The study found that the use of ACEI/ARB after hospital discharge did not increase the risk of recurrent AKI in patients with or without previous AKI during hospitalization. Additionally, there were no significant differences in the risks of death, kidney disease progression, and adjudicated heart-failure events between patients who did and did not experience AKI during hospitalization.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Article Medicine, Research & Experimental

Biomarkers of inflammation and repair in kidney disease progression

Jeremy Puthumana, Heather Thiessen-Philbrook, Leyuan Xu, Steven G. Coca, Amit X. Garg, Jonathan Himmelfarb, Pavan K. Bhatraju, T. Alp Ikizler, Edward D. Siew, Lorraine B. Ware, Kathleen D. Liu, Alan S. Go, James S. Kaufman, Paul L. Kimmel, Vernon M. Chinchilli, Lloyd G. Cantley, Chirag R. Parikh

Summary: The study found that levels of MCP-1 and YKL-40 measured at 3 months after hospitalization were associated with long-term risk of kidney failure, while UMOD levels were linked with decreased risk of kidney injury. Using a multimarker score provided better accuracy in predicting patients' risk of kidney disease progression compared to traditional clinical variables.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Editorial Material Urology & Nephrology

Better Nutrition Care for Patients on Hemodialysis One Step at a Time

T. Alp Ikizler

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Editorial Material Urology & Nephrology

Rescuing kidney patients from early demise: role of anti-cytokine therapies

T. Alp Ikizler, Jonathan Himmelfarb

KIDNEY INTERNATIONAL (2021)

Article Urology & Nephrology

Angiopoietins as Prognostic Markers for Future Kidney Disease and Heart Failure Events after Acute Kidney Injury

Sherry G. Mansour, Pavan K. Bhatraju, Steven G. Coca, Wassim Obeid, Francis P. Wilson, Ian B. Stanaway, Yaqi Jia, Heather Thiessen-Philbrook, Alan S. Go, T. Alp Ikizler, Edward D. Siew, Vernon M. Chinchilli, Chi-yuan Hsu, Amit X. Garg, W. Brian Reeves, Kathleen D. Liu, Paul L. Kimmel, James S. Kaufman, Mark M. Wurfel, Jonathan Himmelfarb, Samir M. Parikh, Chirag R. Parikh, ASSESS-AKI Consortium

Summary: A higher Angpt-1:Angpt-2 ratio is strongly associated with reduced risk of CKD progression, heart failure, and mortality in patients with AKI.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Article Hematology

Hematologic malignancies magnify the effect of body mass index on insulin resistance in cancer survivors

Melis Sahinoz, James M. Luther, Mona Mashayekhi, Dae Kwang Jung, T. Alp Ikizler, Brian G. Engelhardt

Summary: Cancer survivors have an increased risk of developing type 2 diabetes, and the interaction between cancer and body mass index (BMI) can affect insulin sensitivity and glucose regulation.

BLOOD ADVANCES (2022)

Editorial Material Nutrition & Dietetics

Very low-protein diets in advanced kidney disease: safe, effective, but not practical

T. Alp Ikizler

AMERICAN JOURNAL OF CLINICAL NUTRITION (2022)

Editorial Material Urology & Nephrology

Aquaporin-1 variants: a step further towards precise prescription in peritoneal dialysis?

Osama El Shamy, T. Alp Ikizler

KIDNEY INTERNATIONAL (2022)

Article Urology & Nephrology

Disruption of mitochondrial complex III in cap mesenchyme but not in ureteric progenitors results in defective nephrogenesis associated with amino acid deficiency

Nan Guan, Hanako Kobayashi, Ken Ishii, Olena Davidoff, Feng Sha, Talat A. Ikizler, Chuan-Ming Hao, Navdeep S. Chandel, Volker H. Haase

Summary: This study investigates the role of mitochondrial electron transport in kidney homeostasis by inactivating a subunit of mitochondrial complex III in kidney progenitor cells. The results show that mitochondrial oxidative metabolism is critical for kidney development, and inactivation of specific proteins can lead to severe kidney dysplasia or smaller functional kidneys.

KIDNEY INTERNATIONAL (2022)

Editorial Material Urology & Nephrology

Dietary sodium restriction in heart failure and chronic kidney disease: more evidence emerges

Rengin Elsurer Afsar, Talat Alp Ikizler

KIDNEY INTERNATIONAL (2022)

Article Urology & Nephrology

The ASSESS-AKI Study found urinary epidermal growth factor is associated with reduced risk of major adverse kidney events

Steven Menez, Yumeng Wen, Leyuan Xu, Dennis G. Moledina, Heather Thiessen-Philbrook, David Hu, Wassim Obeid, Pavan K. Bhatraju, T. Alp Ikizler, Edward D. Siew, Vernon M. Chinchilli, Amit X. Garg, Alan S. Go, Kathleen D. Liu, James S. Kaufman, Paul L. Kimmel, Jonathan Himmelfarb, Steven G. Coca, Lloyd G. Cantley, Chirag R. Parikh

Summary: Urinary epidermal growth factor (EGF) may serve as a biomarker for tubular function and can be used to assess the risk of chronic kidney disease (CKD) after hospitalization. Higher urinary EGF concentrations three months post-discharge are associated with a reduced risk of major adverse kidney events (MAKE), such as CKD incidence, progression, or kidney failure.

KIDNEY INTERNATIONAL (2023)

Article Urology & Nephrology

Effects of Spironolactone on Arrhythmias in Hemodialysis Patients: Secondary Results of the SPin-D Randomized Controlled Trial

Finnian R. Mc Causland, Jesse Y. Hsu, Jonathan Himmelfarb, Talat Alp Ikizler, Dominic S. Raj, Rajnish Mehrotra, Sushrut S. Waikar, Paul L. Kimmel, Alan S. Kliger, Laura M. Dember, David M. Charytan

Summary: In a post hoc analysis, it was found that spironolactone treatment resulted in a higher frequency of bradycardia and conduction blocks in patients receiving maintenance hemodialysis. Close monitoring is necessary for these patients while awaiting definitive trial results.

KIDNEY360 (2023)

Review Urology & Nephrology

Skeletal muscle energetics in patients with moderate to advanced kidney disease

Lale Ertuglu, Abdulmecit Yildiz, Jorge Gamboa, T. Alp Ikizler

Summary: Sarcopenia, characterized by decreased muscle function and mass, is common in patients with moderate to advanced chronic kidney disease (CKD) and is associated with poor clinical outcomes. Mitochondrial dysfunction is proposed as one of the underlying mechanisms, which is noticeable from the early stages and correlated with disease severity. Uremic toxins, oxidative stress, and systemic inflammation play a role in the development of mitochondrial dysfunction. Therapeutic interventions targeting mitochondrial function, such as coenzyme Q and cardiolipin-targeted peptides, have been tested in early studies. Aerobic exercise, although effective in healthy adults, is not as effective in advanced CKD patients, potentially due to impaired activation of mitochondrial biogenesis. Further research is needed to better understand the pathogenesis of mitochondrial dysfunction and develop targeted therapies for sarcopenia in CKD patients.

KIDNEY RESEARCH AND CLINICAL PRACTICE (2022)

Article Urology & Nephrology

Peripheral Insulin Resistance Is Associated with Copeptin in Patients with Chronic Kidney Disease

Juan Pablo Arroyo, Elvis A. Akwo, Andrew S. Terker, Aseel Alsouqi, Gautam Bhave, Raymond C. Harris, Adriana M. Hung, T. Alp Ikizler

Summary: The study found a significant correlation between peripheral insulin resistance and elevated copeptin levels in patients with CKD, with a 39% increase in copeptin levels for every 1 SD decrease in insulin sensitivity. Further research into how peripheral insulin resistance and elevated vasopressin affect CKD progression could provide valuable insights.

KIDNEY360 (2021)

Article Urology & Nephrology

The Microbiome and p-Inulin in Hemodialysis: A Feasibility Study

Dominic S. Raj, Michael B. Sohn, David M. Charytan, Jonathan Himmelfarb, T. Alp Ikizler, Rajnish Mehrotra, Ali Ramezani, Renu Regunathan-Shenk, Jesse Y. Hsu, J. Richard Landis, Hongzhe Li, Paul L. Kimmel, Alan S. Kliger, Laura M. Dember

Summary: The study found that there is greater variability in gut microbiome and metabolomic composition between individuals with ESKD than within individuals. Treatment with p-inulin was well tolerated and showed signs of increasing microbiome diversity.

KIDNEY360 (2021)

No Data Available